Literature DB >> 33427197

Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

László Bányai1, Maria Trexler1, Krisztina Kerekes1, Orsolya Csuka2, László Patthy1.   

Abstract

A major goal of cancer genomics is to identify all genes that play critical roles in carcinogenesis. Most approaches focused on genes positively selected for mutations that drive carcinogenesis and neglected the role of negative selection. Some studies have actually concluded that negative selection has no role in cancer evolution. We have re-examined the role of negative selection in tumor evolution through the analysis of the patterns of somatic mutations affecting the coding sequences of human genes. Our analyses have confirmed that tumor suppressor genes are positively selected for inactivating mutations, oncogenes, however, were found to display signals of both negative selection for inactivating mutations and positive selection for activating mutations. Significantly, we have identified numerous human genes that show signs of strong negative selection during tumor evolution, suggesting that their functional integrity is essential for the growth and survival of tumor cells.
© 2021, Bányai et al.

Entities:  

Keywords:  cancer biology; cancer gene; human; negative selection; neutral evolution; passenger gene; positive selection

Mesh:

Year:  2021        PMID: 33427197      PMCID: PMC7877913          DOI: 10.7554/eLife.59629

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  318 in total

1.  TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.

Authors:  Ming-Zhu Zhang; Olivier Ferrigno; Zhe Wang; Mutsuko Ohnishi; Céline Prunier; Laurence Levy; Mohammed Razzaque; Williams C Horne; Damian Romero; Guri Tzivion; Frédéric Colland; Roland Baron; Azeddine Atfi
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

2.  Chromatin organization is a major influence on regional mutation rates in human cancer cells.

Authors:  Benjamin Schuster-Böckler; Ben Lehner
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

3.  miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway.

Authors:  Ling Liu; Jianguo Hu; Tinghe Yu; Shuang You; Yulin Zhang; Lina Hu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2019-05-23       Impact factor: 3.848

4.  Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma.

Authors:  Youbo Zhao; Wei Li; Menghuan Li; Yan Hu; Hui Zhang; Guanbin Song; Li Yang; Kaiyong Cai; Zhong Luo
Journal:  Exp Cell Res       Date:  2019-08-31       Impact factor: 3.905

5.  Immunohistochemical Expression of Melatonin Receptor MT1 and Glucose Transporter GLUT1 in Human Breast Cancer.

Authors:  Tialfi B de Castro; André L Mota; Newton A Bordin-Junior; Dalisio S Neto; Debora A P C Zuccari
Journal:  Anticancer Agents Med Chem       Date:  2018       Impact factor: 2.505

6.  C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.

Authors:  D Sun; C Wang; S Long; Y Ma; Y Guo; Z Huang; X Chen; C Zhang; J Chen; J Zhang
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

7.  The evolutionary history of 2,658 cancers.

Authors:  Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner; Stefan C Dentro; Santiago Gonzalez; Daniel Rosebrock; Thomas J Mitchell; Yulia Rubanova; Pavana Anur; Kaixian Yu; Maxime Tarabichi; Amit Deshwar; Jeff Wintersinger; Kortine Kleinheinz; Ignacio Vázquez-García; Kerstin Haase; Lara Jerman; Subhajit Sengupta; Geoff Macintyre; Salem Malikic; Nilgun Donmez; Dimitri G Livitz; Marek Cmero; Jonas Demeulemeester; Steven Schumacher; Yu Fan; Xiaotong Yao; Juhee Lee; Matthias Schlesner; Paul C Boutros; David D Bowtell; Hongtu Zhu; Gad Getz; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Florian Markowetz; Ville Mustonen; Ke Yuan; Wenyi Wang; Quaid D Morris; Paul T Spellman; David C Wedge; Peter Van Loo
Journal:  Nature       Date:  2020-02-06       Impact factor: 49.962

8.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

9.  BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer.

Authors:  Weihong Niu; Yanwei Luo; Xinye Wang; Yao Zhou; Hui Li; Heran Wang; Yaojie Fu; Shanshan Liu; Shanghelin Yin; Jianglei Li; Ran Zhao; Yukun Liu; Songqing Fan; Zheng Li; Wei Xiong; Xiaoling Li; Guiyuan Li; Caiping Ren; Ming Tan; Ming Zhou
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

10.  Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.

Authors:  Florian Haller; Matthias Bieg; Rainer Will; Cindy Körner; Dieter Weichenhan; Alexander Bott; Naveed Ishaque; Pavlo Lutsik; Evgeny A Moskalev; Sarina K Mueller; Marion Bähr; Angelika Woerner; Birgit Kaiser; Claudia Scherl; Marlen Haderlein; Kortine Kleinheinz; Rainer Fietkau; Heinrich Iro; Roland Eils; Arndt Hartmann; Christoph Plass; Stefan Wiemann; Abbas Agaimy
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

View more
  4 in total

1.  Smoke-induced SAV1 Gene Promoter Hypermethylation Disrupts YAP Negative Feedback and Promotes Malignant Progression of Non-small Cell Lung Cancer.

Authors:  Ting Liu; Wei Guo; Kai Luo; Lei Li; Jing Dong; Meijun Liu; Xingyuan Shi; Zhiyuan Wang; Jianlei Zhang; Jiang Yin; Ni Qiu; Minying Lu; Danyang Chen; Xiaoting Jia; Hao Liu; Yixue Gu; Yan Xiong; Guopei Zheng; Gang Xu; Zhimin He; Zhijie Zhang
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

2.  Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth.

Authors:  Rameswari Chilamakuri; Danielle Crystal Rouse; Saurabh Agarwal
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-24

Review 3.  Genetic Variants in Transcription Factor Binding Sites in Humans: Triggered by Natural Selection and Triggers of Diseases.

Authors:  Chia-Chun Tseng; Man-Chun Wong; Wei-Ting Liao; Chung-Jen Chen; Su-Chen Lee; Jeng-Hsien Yen; Shun-Jen Chang
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

4.  Use of Publication Dynamics to Distinguish Cancer Genes and Bystander Genes.

Authors:  László Bányai; Mária Trexler; László Patthy
Journal:  Genes (Basel)       Date:  2022-06-21       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.